Millions of people with overactive bladder syndrome are prescribed daily anticholinergics. But research has linked these ...

Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

Discover how cold weather can trigger prostate problems in men over 60, including frequent urination, hormonal changes, and ...

Anticholinergics are competitive inhibitors of acetylcholine at muscarinic receptors (mainly the M3 receptor subtype), and they thereby inhibit involuntary bladder contractions. [19] The effective ...

Medical experts share their answers to all your questions on bladder problems, from urinary tract infections to odd urine ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

However, if constant therapeutic levels of oxybutynin in the bladder without repeated instrumentation can be achieved, this would provide an extremely effective regimen to OAB. The key to this ...

While drinking adequate water remains essential for health, timing fluid intake can help manage symptoms. Reducing evening fluid consumption often improves nighttime bladder control. Some individuals ...